相关实验视频

Updated: Jan 12, 2026

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

从床边到长椅的抗炎疗法:支持临床前发展的框架

Cristina Cigana¹, Alice Rossi¹, Davide Gugliandolo¹

¹Infections and Cystic Fibrosis Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milano, Italy.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

|October 30, 2025

概括

对呼吸道疾病的抗炎药物进行评估需要更好的临床前模型. 慢性 Pseudomonas aeruginosa 感染模型被证明是测试药物疗效的最有效方法,与 LPS 或急性感染模型不同.

科学领域:

肺部医学肺部医学
药理学药理学是指药理学的学科.
传染性疾病传染性疾病

背景情况:

抗炎疗法对于呼吸系统疾病至关重要,但临床前模型往往无法预测临床疗效.
为了开发有效的抗炎药物,需要改进临床前评估标准和模型.

研究的目的:

为了比较不同的临床前模型的疗效,以评估抗炎疗法.
确定可靠的生物标志物,以评估呼吸道疾病模型中的药物有效性.

主要方法:

在脂多糖 (LPS) 暴露,急性和慢性Pseudomonas aeruginosa肺部感染模型中对阿兹罗密辛,易布洛芬和甲的回顾性评估.
立即与延迟治疗方案的比较 (感染后7天).
评估体重,肺炎标志物 (细胞招募,骨髓氧化酶,中性粒细胞弹性酶,细胞因子) 和细菌负载.

主要成果:

慢性P. aeruginosa感染模型可靠地检测出所有测试药物的治疗作用.
药物改善了体重,减少了肺炎标志物;血细胞计数不那么可靠.
德甲在LPS模型中是有效的,但急性感染模型显示炎症恶化.

结论:

慢性P. aeruginosa感染模型是评估呼吸道疾病抗炎疗法的最合适的临床前模型.
这种未被充分利用的模型应该在临床前抗炎药物测试中得到更广泛的采用.
针对性地减少肺炎和细菌负载是治疗疗效的关键指标.

关键词:

感染感染感染炎症炎症是一种炎症.临床前研究临床前研究呼吸道疾病呼吸道疾病

更多相关视频

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells

Published on: September 18, 2016

相关概念视频

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...

Inflammatory Response

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...